The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems
Abstract
Extracellular vesicles (EVs) are recognized as nature's own carriers to transport macromolecules throughout the body. Hijacking this endogenous communication system represents an attractive strategy for advanced drug delivery. However, efficient and reproducible loading of EVs with therapeutic or imaging agents still represents a bottleneck for their use as a drug delivery system. Here, we developed a method for modifying cell-derived EVs through their fusion with liposomes containing both membrane and soluble cargoes. The fusion of EVs with functionalized liposomes was triggered by polyethylene glycol (PEG) to create smart biosynthetic hybrid vectors. This versatile method proved to be efficient to enrich EVs with exogenous lipophilic or hydrophilic compounds, while preserving their intrinsic content and biological properties. Hybrid EVs improved cellular delivery efficiency of a chemotherapeutic compound by a factor of 3-4, as compared to the free drug or the drug-loaded liposome precursor. On one side, this method allows the biocamouflage of liposomes by enriching their lipid bilayer and inner compartment with biogenic molecules. On the other side, the proposed fusion strategy enables efficient EV loading, and the pharmaceutical development of EVs with adaptable activity and drug delivery property.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Preparation of aqueous magnetic liquids in alkaline and acidic media
Massart, R. (1981) · IEEE Transactions on Magnetics · doi:10.1109/tmag.1981.1061188 · Cited by 2,817
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
ExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,452
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Engineering exosomes as refined biological nanoplatforms for drug delivery
Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.12 · Cited by 1,163
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,041
Deregibus, M. C., Cantaluppi, V., Calogero, R., Lo Iacono, M., Tetta, C., Biancone, L., Bruno, S., Bussolati, B., & Camussi, G. (2007) · Blood · doi:10.1182/blood-2007-03-078709 · Cited by 977
Pascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Webber, J., & Clayton, A. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.19861 · Cited by 817
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
Engineering hybrid exosomes by membrane fusion with liposomes
Sato, Y. T., Umezaki, K., Sawada, S., Mukai, S.-A., Sasaki, Y., Harada, N., Shiku, H., & Akiyoshi, K. (2016) · Scientific Reports · doi:10.1038/srep21933 · Cited by 744
Arraud, N., Linares, R., Tan, S., Gounou, C., Pasquet, J. ‐., Mornet, S., & Brisson, A. R. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12554 · Cited by 740
Kooijmans, S. A. A., Stremersch, S., Braeckmans, K., de Smedt, S. C., Hendrix, A., Wood, M. J. A., Schiffelers, R. M., Raemdonck, K., & Vader, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.014 · Cited by 663
THE BIOLOGICAL SIGNIFICANCE OF THE THROMBOPLASTIC PROTEIN OF BLOOD
Chargaff, E., & West, R. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34997-9 · Cited by 659
PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time
Kooijmans, S. A. A., Fliervoet, L. A. L., van der Meel, R., Fens, M. H. A. M., Heijnen, H. F. G., van Bergen en Henegouwen, P. M. P., Vader, P., & Schiffelers, R. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.009 · Cited by 625
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
Armstrong, J. P. K., Holme, M. N., & Stevens, M. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07607 · Cited by 602
Imai, T., Takahashi, Y., Nishikawa, M., Kato, K., Morishita, M., Yamashita, T., Matsumoto, A., Charoenviriyakul, C., & Takakura, Y. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26238 · Cited by 579
Tan, C. Y., Lai, R. C., Wong, W., Dan, Y. Y., Lim, S.-K., & Ho, H. K. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt465 · Cited by 548
Kedmi, R., Ben-Arie, N., & Peer, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.027 · Cited by 546
Exosomes are natural carriers of exogenous siRNA to human cells in vitro
Shtam, T. A., Kovalev, R. A., Varfolomeeva, E. Y., Makarov, E. M., Kil, Y. V., & Filatov, M. V. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-88 · Cited by 499
Lee, T. H., D’Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B., & Rak, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0250-3 · Cited by 494
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
van der Meel, R., Fens, M. H. A. M., Vader, P., van Solinge, W. W., Eniola-Adefeso, O., & Schiffelers, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.049 · Cited by 482
Extracellular vesicles: emerging targets for cancer therapy
Vader, P., Breakefield, X. O., & Wood, M. J. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.002 · Cited by 421
Ridder, K., Keller, S., Dams, M., Rupp, A.-K., Schlaudraff, J., Del Turco, D., Starmann, J., Macas, J., Karpova, D., Devraj, K., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001874 · Cited by 412
Lamichhane, T. N., Raiker, R. S., & Jay, S. M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00364 · Cited by 410
Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Boulanger, C. M., Amabile, N., & Tedgui, A. (2006) · Hypertension · doi:10.1161/01.hyp.0000231507.00962.b5 · Cited by 372
Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H.-G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 366
Chernomordik, L. V., Frolov, V. A., Leikina, E., Bronk, P., & Zimmerberg, J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1369 · Cited by 363
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages
Momen-Heravi, F., Bala, S., Bukong, T., & Szabo, G. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.03.014 · Cited by 306
Parlati, F., Weber, T., McNew, J. A., Westermann, B., Söllner, T. H., & Rothman, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12565 · Cited by 262
Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., Albert, A., Shnayder, R., Gobezie, R., Nigrovic, P. A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201846 · Cited by 254
Pusic, A. D., & Kraig, R. P. (2014) · Glia · doi:10.1002/glia.22606 · Cited by 242
Cutting-Edge Analysis of Extracellular Microparticles using ImageStreamX Imaging Flow Cytometry
Headland, S. E., Jones, H. R., D'Sa, A. S. V., Perretti, M., & Norling, L. V. (2014) · Scientific Reports · doi:10.1038/srep05237 · Cited by 211
Kervadec, A., Bellamy, V., El Harane, N., Arakélian, L., Vanneaux, V., Cacciapuoti, I., Nemetalla, H., Périer, M.-C., Toeg, H. D., Richart, A., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.013 · Cited by 205
Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane
Tan, S. S., Yin, Y., Lee, T., Lai, R. C., Yeo, R. W. Y., Zhang, B., Choo, A., & Lim, S. K. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.22614 · Cited by 192
PEG as a tool to gain insight into membrane fusion
Lentz, B. R. (2007) · European Biophysics Journal · doi:10.1007/s00249-006-0097-z · Cited by 190
Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting
Silva, A. K. A., Luciani, N., Gazeau, F., Aubertin, K., Bonneau, S., Chauvierre, C., Letourneur, D., & Wilhelm, C. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.11.009 · Cited by 164
Self-citationLee, J., Lee, H., Goh, U., Kim, J., Jeong, M., Lee, J. Y. H., & Park, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01315 · Cited by 156
Microparticles and immunomodulation in pregnancy and pre-eclampsia
Redman, C. W. G., & Sargent, I. L. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.03.008 · Cited by 150
Lentz, B. R., & Lee, J. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294508 · Cited by 143
SNAREs can promote complete fusion and hemifusion as alternative outcomes
Giraudo, C. G., Hu, C., You, D., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501093 · Cited by 138
EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research
Kim, D., Lee, J., Simpson, R. J., Lötvall, J. O., & Gho, Y. S. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.02.005 · Cited by 126
SNAREpin/Munc18 promotes adhesion and fusion of large vesicles to giant membranes
Tareste, D. C., Shen, J., Melia, T. J., & Rothman, J. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712125105 · Cited by 123
Self-citationSilva, A., Kolosnjaj‐Tabi, J., Bonneau, S., Marangon, I., Boggetto, N., Aubertin, K., Clémеnt, O., Bureau, M. F., Luciani, N., Gazeau, F., et al. (2013) · ACS Nano · doi:10.1021/nn400269x · Cited by 119
Self-citationHe, J., Banizs, A. B., Huang, T., Dryden, K. A., Berr, S. S., Stone, J. R., Nakamoto, R. K., & Shi, W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64267 · Cited by 95
Garikipati, V. N. S., Krishnamurthy, P., Verma, S. K., Khan, M., Abramova, T. V., Mackie, A. R., Qin, G., Benedict, C., Nickoloff, E., Johnson, J. A., et al. (2015) · Stem Cells · doi:10.1002/stem.2121 · Cited by 77
Lipid Mixing and Content Release in Single-Vesicle, SNARE-Driven Fusion Assay with 1–5 ms Resolution
Wang, T., Smith, E. A., Chapman, E. R., & Weisshaar, J. C. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.02.050 · Cited by 77
Liposome Fusion Assay to Monitor Intracellular Membrane Fusion Machines
Scott, B. L., Komen, J. S. V., Liu, S., et al. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)72016-3 · Cited by 74
Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Tumor Growth
Bruno, S., Collino, F., Iavello, A., & Camussi, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00382 · Cited by 68
Microvesicles: ubiquitous contributors to infection and immunity
Lai, F. W., Lichty, B. D., & Bowdish, D. M. E. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0513-292rr · Cited by 67
Faraj, A. A., Gazeau, F., Wilhelm, C., Devue, C., Guérin, C. L., Péchoux, C., Paradis, V., Clémеnt, O., Boulanger, C. M., & Rautou, P. (2012) · Radiology · doi:10.1148/radiol.11111329 · Cited by 44
Self-citationMembrane lysis during biological membrane fusion: collateral damage by misregulated fusion machines
Engel, A., & Walter, P. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805182 · Cited by 42
Magnetophoresis at The Nanoscale: Tracking The Magnetic Targeting Efficiency of Nanovectors
Silva, A., Corato, R. D., Gazeau, F., Pellegrino, T., & Wilhelm, C. (2012) · Nanomedicine · doi:10.2217/nnm.12.40 · Cited by 39
Self-citationVersluis, A. J., Rump, E. T., Rensen, P. C. N., van Berkel, T. J. C., & Bijsterbosch, M. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38099-1 · Cited by 31
Cited by
Extracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948
Engineering exosomes for targeted drug delivery
Liang, Y., Duan, L., Lu, J., & Xia, J. (2021) · Theranostics · doi:10.7150/thno.52570 · Cited by 1,547
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Yang, Q., Guo, N., Zhou, Y., Chen, J., Wei, Q., & Han, M. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.004 · Cited by 471
Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery
Rayamajhi, S., Nguyen, T. D. T., Marasini, R., & Aryal, S. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.054 · Cited by 429
Metadata
- Authors
- Piffoux, M., Silva, A. K. A., Wilhelm, C., Gazeau, F., & Tareste, D.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-07-05
- Volume
- 12
- Issue
- 7
- Pages
- 6830-6842
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2827777376
- Cited by
- 456
- References
- 68
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.